PubRank

M T Drayson

Author PubWeight™ 28.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001 3.94
2 Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 2005 2.15
3 Serum free light chains for monitoring multiple myeloma. Br J Haematol 2004 2.07
4 The stable and permanent expansion of functional T lymphocytes in athymic nude rats after a single injection of mature T cells. J Immunol 1987 1.67
5 Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemost 2011 1.31
6 A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults. Br J Haematol 1998 1.30
7 Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma. Br J Haematol 2001 1.19
8 The sequence of changes in blood flow and lymphocyte influx to stimulated rat lymph nodes. Immunology 1981 1.11
9 Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production. Blood Cancer J 2011 0.96
10 Afferent lymph and lymph borne cells: their influence on lymph node function. Immunobiology 1984 0.95
11 Effect of prolonged exercise and carbohydrate ingestion on type 1 and type 2 T lymphocyte distribution and intracellular cytokine production in humans. J Appl Physiol (1985) 2004 0.94
12 Detection of Bence Jones myeloma and monitoring of myeloma chemotherapy using immunoassays specific for free immunoglobulin light chains. Clin Lab 2003 0.93
13 Estrone potentiates myeloid cell differentiation: a role for 17 beta-hydroxysteroid dehydrogenase in modulating hemopoiesis. Exp Hematol 1999 0.93
14 Monocytically differentiating HL60 cells proliferate rapidly before they mature. Exp Cell Res 1999 0.92
15 The origin of T cells in permanently reconstituted old athymic nude rats. Analysis using chromosome or allotype markers. Immunology 1989 0.92
16 The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction. Eur J Immunol 1985 0.90
17 Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease. Leukemia 2003 0.88
18 Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2. Leukemia 2008 0.88
19 The toxicity, distribution and excretion of ricin holotoxin in rats. Toxicology 1989 0.88
20 Complement and the recruitment of mononuclear osteoclasts. J Clin Pathol 1993 0.82
21 A comparison between antigen-laden cells and dendritic cells in afferent and efferent lymph. Adv Exp Med Biol 1985 0.80
22 Clofibric acid: a potential therapeutic agent in AML and MDS. Br J Haematol 1999 0.78
23 Metabolism of 1alpha,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation. Mol Cell Endocrinol 1999 0.78
24 The entry of lymphocytes into stimulated lymph nodes. The site of selection of alloantigen-specific cells. Transplantation 1986 0.78
25 Lymphocyte targeted ricin as a potential therapy for lymphoid malignancy. I. Targeting efficiency. Br J Cancer 1991 0.75
26 Renal impairment in myeloma: time for a reappraisal? Nephrol Dial Transplant 1998 0.75
27 Triiodothyronine blocks potentiation of HL60 monocyte differentiation by anti-inflammatory agents and by steroids and induces apoptosis of all-trans retinoic acid "primed" cells. Leuk Res 1997 0.75
28 Total serum IgE and IgE antibodies specific to house dust mite found in two aged-matched cohorts of children with and without otitis media with effusion. Clin Otolaryngol 2006 0.75
29 Thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991 0.75